Agree with Dr. Cao above.

培养方式 is to much difference.

In the US: before you become a pathologist, you need to have 4 year university study (mostly biology major), 4 year medical shool, 4 year pathology resident training and 1-2 year fellow ship training.  During the resident and fellowship years (5-6 years), the main duties are to read many slides, cases with supervised by pathologists rotate in all subspecielties of pathology, attend many department educational conferences, present cases in department. One target for residents and fellows  is to learn pathology. They can not sign out any single case independly. 

In China we can be called pathologists after we graduate from medical school and find a job in pathology department. Think about how much pathology knowledge you have remembered. Of cause I know that many people will continue to study for master or PhD in pathology. This may improve the quality of pathology. However, Master or PhD study is more for sciense and research, not true clinical diagnosis.

Correct me if I am wrong.

在国外做病理医生是要考执照的，必须经过严格的住院医师训练。

不知道您提问“没有临床医生的经验，病理医生能成为医生的医生吗？”的具体意思是什么？因为病理学是桥梁学科，即要有临床知识、又要有基础知识，主要通过形态学将二者融汇贯通。

我曾经讲到病理诊断中的“二个回归”

IHC和分子病理要回归形态、病理诊断要回归临床。病理诊断最重要的是回答临床医生的问题，如病变的性质、病变的严重程度、病变的范围、病人的预后指标、对治疗的建议、等等......。

有些热衷于分子病理诊断的医生断言：将来传统病理医生要失业了，分子病理诊断可完全替代组织病理诊断。我认为那是非常非常遥远的事。举个例子，Hodgkin 淋巴瘤的研究已经有150多年，对其肿瘤细胞来源的假说是一种又一种，但是，R-S细胞还是R-S细胞，丝毫不变！人体太复杂，个体的发育、整体的神经体液调节，同样一种因子在不同的时间和空间，作用却不同。这是用一个分子或几条信号通路无法彻底解释的。病变的质变和量变问题、没有肿块的分子改变对优生可进行筛选、对于非实体瘤可进行诊断，对于实体瘤呢？ 当然，作为科学的进步，分子病理使病理医生能从DNA/RNA等分子的角度去探索发病机制、辅助鉴别诊断，比IHC（蛋白质水平）有了很大的进步。人类基因图的破译是一大进步，但是还没高兴几天又产生了更多的迷惑，上帝是如何创造人类的？

 很同意5楼老师的发言。

各科医生分工合作，共同对付疾病，各自从不同的角度来认识疾病，积累经验。